Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 139,924 | 152,981 | 114,472 | 196,676 | 113,026 |
| Operating Income | -139,924 | -152,981 | -114,472 | -196,676 | -113,026 |
| Other Income | 36,800 | 24,278 | 19,452 | 15,875 | 20,362 |
| Pre-tax Income | -103,124 | -128,703 | -95,020 | -180,801 | -92,664 |
| Net Income Continuous | -103,124 | -128,703 | -95,020 | -180,801 | -92,664 |
| Net Income | $-103,124 | $-128,703 | $-95,020 | $-180,801 | $-92,664 |
| EPS Basic Total Ops | -0.83 | -1.10 | -0.85 | -1.83 | -0.91 |
| EPS Basic Continuous Ops | -0.83 | -1.10 | -0.85 | -1.83 | -0.91 |
| EPS Diluted Total Ops | -0.83 | -1.10 | -0.85 | -1.83 | -0.91 |
| EPS Diluted Continuous Ops | -0.83 | -1.10 | -0.85 | -1.83 | -0.91 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -1.10 | -0.85 | N/A | N/A |
| EBITDA(a) | $-141,536 | $-159,437 | $-122,372 | $-196,097 | $-125,118 |